Prazosin for PTSD and blood sugar in veterans
Treatments studied
Part of Hormones & metabolism, Mental health clinical trials.
This study tests whether prazosin, a blood pressure medicine, can improve PTSD symptoms and blood sugar control in veterans. It may help if you have PTSD and are not diabetic.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a veteran of the US military.
- You have a PTSD diagnosis confirmed by a clinician.
- You do not have diabetes (except for very early, untreated type 2 diabetes).
- You are not taking certain medications like prazosin, clonidine, or opioids in the past 2 weeks.
- You have not used antipsychotics, steroids, or diabetes medicines in the past 3 months.
- You do not have a history of moderate or severe traumatic brain injury.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a treatment plan for insomnia (trouble sleeping) in older adults who also have post-traumatic stress disorder (PTSD). The goal is to see whether improving sleep also supports heart and metabolic health (such as blood sugar and heart-related measures).
This study tests whether a combination of two investigational drugs, psilocybin and MDMA, can help veterans with post-traumatic stress disorder (PTSD). You would receive the drugs in a controlled setting and be monitored closely.
This Phase 3 study tests whether low-dose clonidine can reduce PTSD symptoms and especially nightmares in U.S. veterans. You’d be screened for PTSD severity and current treatments, then asked to visit the clinic as scheduled to see if the treatment helps.
This trial tests a study medicine that blocks the effects of cortisol (a stress hormone) to reduce PTSD symptoms in Veterans. It’s meant for people with ongoing PTSD symptoms and stable treatments, and it closely checks safety because the medicine can affect sleep, mood, and heart rhythm.
This Phase 2 study looks at how stress-related nerve activity and a hormone called angiotensin II may be involved in PTSD, and how specific blood-pressure-related medicines affect the body. You may be eligible if you are a PTSD patient (or a matched control without PTSD) and meet safety criteria.
This Phase 2 trial studies pimavanserin, a medicine meant to improve insomnia, in veterans who also have PTSD. It may help reduce problems with falling asleep, staying asleep, or waking too early that affect daytime functioning.
Hear when a new Posttraumatic Stress Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.